Quick Answer: Glutathione supplementation is contraindicated for people currently on chemotherapy (due to potential interference with oxidative treatment mechanisms), those with G6PD deficiency, and should be approached cautiously during pregnancy and before surgery. For healthy adults without these conditions, the safety profile at typical supplemental doses is well established. The reason most doctors don't prescribe it is structural — not because it doesn't work.
Most articles about glutathione lead with what it can do for your skin, your energy, or your aging markers. This one starts differently. Before discussing benefits, it is worth being direct about the populations for whom glutathione supplementation warrants either avoidance or medical supervision.
This is not a reason to avoid glutathione if none of these situations apply to you. It is a reason to know which group you are in before starting.
1. The Most Important Group: Anyone on Chemotherapy
This is the contraindication that matters most, and it is the one most supplement brands skip.
Several common chemotherapy agents — including platinum-based drugs like cisplatin and oxaliplatin, as well as certain alkylating agents — work in part through oxidative mechanisms. They generate reactive oxygen species (ROS) that damage cancer cell DNA, contributing to cell death. This is by design.
Glutathione is one of the primary cellular defenses against oxidative damage. There is a theoretical and partially evidenced concern that supplementing with glutathione or antioxidants in general could reduce chemotherapy efficacy by protecting cancer cells from the oxidative stress that makes the treatment work.
The evidence on this is not fully resolved. Some researchers have argued that certain antioxidants selectively protect normal cells and not cancer cells; others have raised concerns about interference. A 2008 review by Lawenda et al. in the Journal of the National Cancer Institute raised specific concerns about antioxidant supplementation during chemotherapy, recommending caution. Some oncologists use IV glutathione specifically to reduce chemotherapy side effects, which reflects the complexity of the question.
The bottom line for supplemental glutathione in an over-the-counter context: if you are currently undergoing chemotherapy, do not take glutathione supplements without an explicit conversation with your oncologist. This is not a negotiable precaution. Your oncologist needs to be part of this decision.
2. G6PD Deficiency and Hemolytic Conditions
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition affecting red blood cell metabolism. G6PD is an enzyme that plays a key role in the pentose phosphate pathway, which among other functions generates NADPH — a molecule required for regenerating reduced glutathione within red blood cells.
People with G6PD deficiency have reduced capacity to maintain adequate reduced glutathione in their red blood cells. When these cells are exposed to oxidative stress — from certain medications, foods like fava beans, or infections — the resulting glutathione depletion can trigger hemolysis (red blood cell destruction), causing hemolytic anemia.
The implications for glutathione supplementation in G6PD-deficient individuals are not fully established in the clinical literature. The concern is not straightforward: some researchers have proposed that supporting systemic glutathione levels could theoretically be beneficial in G6PD deficiency, while others note that the issue is enzymatic rather than substrate-level. Regardless, G6PD deficiency affects the fundamental biochemistry of glutathione metabolism in a way that warrants physician involvement before supplementation.
If you have G6PD deficiency, discuss glutathione and NAC supplementation with your hematologist before starting.
3. Pre-Surgery Considerations
NAC (N-Acetyl Cysteine) is frequently included in glutathione support formulas because it is the rate-limiting precursor for intracellular glutathione synthesis. NAC has a mild anticoagulant effect at supplemental doses, likely through mechanisms related to reduced platelet aggregation and antioxidant activity.
Many integrative medicine practitioners and some conventional surgeons recommend pausing NAC supplementation 1–2 weeks before any elective surgical procedure. This is consistent with the general guidance to pause antiplatelet supplements (fish oil, vitamin E, etc.) before surgery.
Standard glutathione supplements do not carry the same direct anticoagulant concern, but the combination formula context — where NAC is typically present alongside glutathione — makes this consideration relevant for anyone scheduled for surgery.
If you have a procedure coming up, inform your surgical team of all supplements you are taking. Most will advise a general supplement pause of 7–14 days pre-surgery.
4. Pregnancy and Nursing
There is insufficient clinical data on the safety of supplemental glutathione at wellness doses during pregnancy or nursing.
NAC has been used in clinical settings during pregnancy — notably in cases of acetaminophen overdose, where it is the standard of care, and in some research on preterm labor. However, therapeutic clinical use under medical supervision is a different context from daily supplemental use for skin or antioxidant support.
Glutathione is a naturally occurring molecule present in all cells, including in the placenta and breast milk. Endogenous glutathione is not a concern during pregnancy. The question is whether supplemental doses beyond normal dietary exposure introduce risk — and that data simply does not exist at the level required to make a confident safety statement.
The default position: if you are pregnant or nursing, consult your OB-GYN or midwife before adding glutathione or NAC to your supplement routine. Do not take a supplement brand's assurances on this at face value — that decision belongs with your physician.
5. Drug Interactions Worth Knowing
Chemotherapy agents: As described above. The primary concern.
Immunosuppressants: Glutathione supports immune function, including T-cell activity. In theory, immune-supporting supplements could work against immunosuppressant medications used in transplant recipients or for autoimmune conditions. The clinical data on this specific interaction is limited, but the precaution is reasonable for anyone on chronic immunosuppression. Discuss with your prescribing physician.
Anticoagulants and antiplatelet drugs: NAC's mild antiplatelet properties create a potential additive effect with anticoagulant medications like warfarin or antiplatelet drugs like clopidogrel. This interaction is unlikely to be clinically significant at typical supplement doses in healthy adults, but it warrants disclosure to your physician if you are on anticoagulant therapy.
Nitroglycerin: NAC has been studied alongside nitroglycerin (used for angina) and may potentiate its vasodilatory effects, potentially causing significant hypotension. This interaction is well documented at clinical NAC doses; supplemental doses carry lower risk, but the interaction is worth noting for anyone with cardiovascular conditions managed with nitrates.
6. "Why Don't Doctors Prescribe Glutathione?" — The Real Answer
This question comes up frequently, often framed as evidence that glutathione doesn't work. The actual answer is more structural than scientific.
Reason 1: IV glutathione is used in medicine — just not for skin.
Intravenous glutathione is administered in some clinical settings, including for Parkinson's disease (where it has been studied for symptom management and neuroprotection), for liver conditions including drug-induced liver injury, and in some integrative oncology protocols. The clinical use of glutathione exists — it just exists in contexts where IV administration makes sense.
Reason 2: Supplements are not in most physicians' training.
Medical education in the United States and most developed countries does not substantively cover nutraceuticals, evidence-based supplementation, or the nutritional biochemistry of micronutrients like glutathione. This is a curriculum gap, not a signal about clinical evidence. A physician who isn't aware of the GlyNAC trials or the S-Acetyl Glutathione literature isn't in a position to prescribe or recommend it — but that reflects training, not efficacy.
Reason 3: Supplements cannot be patented in the same way.
The pharmaceutical business model depends on patent protection for novel molecules. Glutathione and NAC are naturally occurring compounds that cannot be exclusively patented. Without exclusivity, there is limited commercial incentive to fund the large-scale clinical trials required for drug approval. This means the evidence base, while meaningful, does not match the scale of pharmaceutical trial data — not because the compounds don't work, but because the funding model is different.
Reason 4: Oral bioavailability was a legitimate barrier — now being addressed.
The historical concern that oral glutathione was poorly absorbed was scientifically legitimate. Newer forms like S-Acetyl Glutathione and liposomal glutathione have improved this picture, but many physicians' knowledge reflects the earlier understanding.
The short answer to "why don't doctors prescribe it": the barrier is structural, not scientific.
7. For Healthy Adults: What the Safety Profile Actually Looks Like
For healthy adults without the contraindications listed above, the safety data on glutathione and NAC supplementation at typical doses is well established.
NAC: NAC has a long clinical track record, including decades of use as a mucolytic agent and as the standard treatment for acetaminophen overdose. It is classified as generally recognized as safe (GRAS) by the FDA when used as a supplement. The most common adverse effects at supplemental doses (600–1200 mg/day) are gastrointestinal: nausea, bloating, and occasionally loose stools. These are dose-dependent and typically resolve with dose reduction. At very high clinical doses, NAC can cause bronchospasm and anaphylactoid reactions when given IV — not relevant to oral supplementation.
Glutathione (oral, supplemental doses): The safety profile for oral glutathione at supplemental doses (typically 250–500 mg/day) is well-tolerated in published clinical trials. Gastrointestinal discomfort is the most commonly reported side effect. A 2017 randomized controlled trial by Weschawalit et al. (Clinical, Cosmetic and Investigational Dermatology) examining 500 mg/day oral glutathione for 12 weeks found no adverse events.
S-Acetyl Glutathione: Available safety data at supplemental doses do not indicate concerns beyond the mild GI effects seen with other forms.
The summary position: for a healthy adult without the contraindications above, glutathione supplementation at typical doses carries a low adverse effect profile. The main practical issue for most people is tolerability (GI comfort), not safety.
8. Who This Is For
GLO+ (GLOPLUS+) contains S-Acetyl Glutathione, NAC, Vitamin C, Alpha Lipoic Acid, and Selenium. It is formulated for healthy adults seeking to support skin health and antioxidant status as part of a broader wellness routine.
If you have any of the conditions listed above, please consult your physician before starting any glutathione supplement. This includes anyone currently on chemotherapy, anyone with G6PD deficiency or hemolytic conditions, anyone on immunosuppressants or anticoagulants, and anyone who is pregnant or nursing.
For healthy adults without these conditions, GLO+ is designed to support the glutathione and antioxidant recycling system through a multi-component formula grounded in the mechanisms described above. The decision to supplement should always be an informed one — which is why this article exists.
